The new CEO will be Cynthia Collins, from GE Healthcare. Collins hold a BS in microbiology and an MBA from University of Chicago; she's worked successively at Abbott, Baxter, Sequoia Pharmaceuticals, Beckman Coulter, GenVec, and GE Healthcare for IVD research and applied markets.
Venter is one of the most accomplished and well-known living biologists. HLI completed $220M in Series B fundraising in April 2016. On a personal note, my career in consulting began in October 2001, when Accenture assigned me (as a physician with a fresh MBA) to a strategy team working at Venter's company Celera in Maryland. Fifteen years later, I'm still doing strategy consulting in genomics!
